Stock PGNY PROGYNY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Progyny, Inc.

Equities

PGNY

US74340E1038

Real-time Estimate Cboe BZX
Other stock markets
 01:31:12 2024-06-10 pm EDT 		5-day change 1st Jan Change
27.52 USD -0.27% Intraday chart for Progyny, Inc. -0.93% -25.79%
May. 23 Transcript : Progyny, Inc. - Shareholder/Analyst Call
May. 22 Progyny Gets Board Approval for $100 Million Share Repurchase Program; Stock Rises After Hours MT

Evolution of the average Target Price on Progyny, Inc.

Price target over the last 5 years

History of analyst recommendation changes

d53afb1bbae8088329cdc76.dj8IFyV1BoIEoL03Hl29srbNBkD2xXPlSa6G1brzEws.EA5bcEkqMbZGx94GUT7Wiv-pViSBkRHRCNjWvvCydV4kDkFScRNttynF5A~e3bd07c7e2464eae1c02504bda04f75b

Analyst Recommendations on Progyny, Inc.

Truist Securities Cuts Price Target on Progyny to $37 From $46, Keeps Buy Rating MT
KeyBanc Downgrades Progyny to Sector Weight From Overweight, Cites Questions on Visibility, 'Potential Further Headwinds' MT
KeyBanc Adjusts Price Target on Progyny to $43 From $45, Maintains Overweight Rating MT
Truist Securities Adjusts Price Target on Progyny to $47 From $52, Maintains Buy Rating MT
KeyBanc Adjusts Progyny Price Target to $45 From $50, Maintains Overweight Rating MT
JPMorgan Adjusts Progyny Price Target to $57 From $58, Maintains Overweight Rating MT
Canaccord Genuity Initiates Progyny With Buy Rating, Price Target is $46 MT
Cantor Fitzgerald Raises Price Target on Progyny to $48 From $45, Maintains Overweight Rating MT
Truist Securities Raises Progyny Price Target to $52 From $48, Maintains Buy Rating MT
Keybanc Adjusts Price Target on Progyny to $50 From $45, Keeps Overweight Rating MT
BTIG Starts Progyny at Buy With $50 Price Target MT
Cantor Fitzgerald Adjusts Price Target on Progyny to $45 From $44, Maintains Overweight Rating MT
Cantor Fitzgerald Initiates Progyny at Overweight With $44 Price Target MT
SVB Securities Downgrades Progyny to Market Perform From Outperform, Adjusts Price Target to $34 From $59 MT
KeyBanc Capital Markets Adjusts Price Target on Progyny to $45 From $55, Maintains Overweight Rating MT
JPMorgan Chase Adjusts Price Target on Progyny to $62 From $78, Maintains Overweight Rating MT
Berenberg Bank Adjusts Progyny Price Target to $55 From $58, Maintains Buy Rating MT
KeyBanc Starts Progyny at Overweight With $55 Price Target MT
Truist Securities Starts Progyny at Buy With $56 Price Target MT
Berenberg Bank Adjusts Progyny's Price Target to $58 From $66, Maintains Buy Rating MT
Berenberg Bank Adjusts Progyny's Price Target to $66 From $70, Maintains Buy Rating MT
Berenberg Bank Adjusts Progyny's Price Target to $70 From $71, Maintains Buy Rating MT
Berenberg Bank Adjusts Progyny's Price Target to $71 From $80, Maintains Buy Rating MT
Jefferies Starts Progyny at Buy with $60 Price Target MT
Citigroup Downgrades Progyny to Neutral From Buy, Adjusts Price Target to $64 From $60 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
27.6 USD
Average target price
38 USD
Spread / Average Target
+37.68%
High Price Target
48 USD
Spread / Highest target
+73.91%
Low Price Target
30 USD
Spread / Lowest Target
+8.70%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Progyny, Inc.

Truist Securities
KeyBanc Capital Markets
JPMorgan Chase
Canaccord Genuity
Cantor Fitzgerald
BTIG
SVB Securities LLC
Berenberg Bank
Jefferies & Co.
Citigroup
Barclays
Guggenheim
SVB Leerink
BofA Securities

Ratings for Progyny, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PGNY Stock
  4. Consensus Progyny, Inc.